• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病状态下药物作用的动力学。二十一。药物输注速率与产生药理效应所需剂量之间的关系。

Kinetics of drug action in disease states. XXI. Relationship between drug infusion rate and dose required to produce a pharmacologic effect.

作者信息

Klockowski P M, Levy G

机构信息

Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo, Amherst 14260.

出版信息

J Pharm Sci. 1987 Jul;76(7):516-20. doi: 10.1002/jps.2600760705.

DOI:10.1002/jps.2600760705
PMID:3668811
Abstract

Computer simulations were performed to determine if the threshold dose of an infused drug (rather than the drug concentration in the biophase at onset of action) can be a suitable index for pharmacodynamic investigations as proposed by others. A two-compartment pharmacokinetic model with drug elimination from the central compartment was used for the simulations. Drug was administered into the central compartment by a constant-rate infusion, and concentrations in the central and peripheral compartments were calculated as a function of time. The pharmacologic effect was assumed to be reversible and to occur at a defined concentration (the effective concentration) in one or the other compartment. The dose required to produce an effective concentration (threshold dose) was determined as a function of infusion rate. The relationship between infusion rate and the dose required to produce an effective concentration in the peripheral compartment was found to be affected by drug distribution and elimination kinetics and by the effective concentration. The infusion rate-dose relationship showed a dose minimum at an infusion rate which others have designated as the "optimal dose rate" and have used for pharmacodynamic studies. No such minimum occurred for pharmacologic effects associated directly with drug concentrations in the central compartment. Since optimum dose rate and threshold dose are affected by both pharmacokinetic and pharmacodynamic alterations, it is concluded that this method (which avoids determination of drug concentrations) is not generally suitable for quantitative pharmacodynamic investigations.

摘要

进行了计算机模拟,以确定输注药物的阈值剂量(而非作用开始时生物相中的药物浓度)是否能如其他人所提议的那样,成为药效学研究的合适指标。模拟采用了一个具有从中央室消除药物功能的二室药代动力学模型。药物通过恒速输注进入中央室,并计算中央室和外周室中的浓度随时间的变化。假定药理效应是可逆的,且在一个或另一个室中在特定浓度(有效浓度)时发生。产生有效浓度所需的剂量(阈值剂量)被确定为输注速率的函数。发现外周室中产生有效浓度所需的输注速率与剂量之间的关系受药物分布和消除动力学以及有效浓度的影响。输注速率 - 剂量关系在一个输注速率处显示出剂量最小值,其他人已将该输注速率指定为“最佳剂量率”并用于药效学研究。与中央室中药物浓度直接相关的药理效应未出现这种最小值。由于最佳剂量率和阈值剂量受药代动力学和药效学改变的影响,得出的结论是,这种方法(避免了药物浓度的测定)通常不适用于定量药效学研究。

相似文献

1
Kinetics of drug action in disease states. XXI. Relationship between drug infusion rate and dose required to produce a pharmacologic effect.疾病状态下药物作用的动力学。二十一。药物输注速率与产生药理效应所需剂量之间的关系。
J Pharm Sci. 1987 Jul;76(7):516-20. doi: 10.1002/jps.2600760705.
2
Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.输注速率对硫喷妥钠剂量-反应关系的影响。药代动力学-药效学模型的评估。
Anesthesiology. 1994 Aug;81(2):316-24; discussion 25A.
3
Pharmacokinetic-pharmacodynamic relationship.药代动力学-药效学关系
Ann Rech Vet. 1990;21 Suppl 1:29S-40S.
4
The maximum pharmacodynamic effect as a response parameter: pharmacokinetic considerations.
J Pharm Pharmacol. 1999 Sep;51(9):999-1008. doi: 10.1211/0022357991773465.
5
Kinetics of drug action: an overview.
J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):754-61. doi: 10.1016/0091-6749(86)90057-6.
6
Pharmacokinetic-based minibolus delivery as an alternative to continuous infusion for drugs that exhibit a biophase lag.基于药代动力学的微量注射给药作为具有生物相滞后的药物连续输注的替代方法。
J Pharmacokinet Biopharm. 1997 Apr;25(2):191-208. doi: 10.1023/a:1025732129798.
7
The effect of infusion time on the time course of drug concentration in blood.
J Pharmacokinet Biopharm. 1980 Dec;8(6):573-82. doi: 10.1007/BF01060054.
8
Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance.利用药代动力学-药效学关系预测依从性差的影响。
Clin Pharmacokinet. 2002;41(1):1-6. doi: 10.2165/00003088-200241010-00001.
9
Influence of intravenous infusion duration on the tissue drug concentration profile.静脉输注持续时间对组织药物浓度分布的影响。
J Pharmacokinet Biopharm. 1986 Jun;14(3):323-34. doi: 10.1007/BF01106710.
10
Pharmacokinetic-pharmacodynamic (PK-PD) modelling in non-steady-state studies and arterio-venous drug concentration differences.非稳态研究中的药代动力学-药效学(PK-PD)建模及动静脉药物浓度差异
Br J Clin Pharmacol. 1994 Nov;38(5):389-400. doi: 10.1111/j.1365-2125.1994.tb04372.x.

引用本文的文献

1
Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models.疾病状态下药物作用的动力学:迈向基于生理学的药效学(PBPD)模型。
J Pharmacokinet Pharmacodyn. 2015 Oct;42(5):447-62. doi: 10.1007/s10928-015-9437-x. Epub 2015 Aug 30.